BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

762 related articles for article (PubMed ID: 19178539)

  • 1. Allergenicity and immunogenicity of the major mugwort pollen allergen Art v 1 chemically modified by acetylation.
    Perovic I; Milovanovic M; Stanic D; Burazer L; Petrovic D; Milcic-Matic N; Gafvelin G; van Hage M; Jankov R; Cirkovic Velickovic T
    Clin Exp Allergy; 2009 Mar; 39(3):435-46. PubMed ID: 19178539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of IgE-binding to Art v 1, Art v 4 and Amb a 1 in mugwort-allergic patients.
    Oberhuber C; Ma Y; Wopfner N; Gadermaier G; Dedic A; Niggemann B; Maderegger B; Gruber P; Ferreira F; Scheiner O; Hoffmann-Sommergruber K
    Int Arch Allergy Immunol; 2008; 145(2):94-101. PubMed ID: 17823540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artemisia and Ambrosia hypersensitivity: co-sensitization or co-recognition?
    Asero R; Wopfner N; Gruber P; Gadermaier G; Ferreira F
    Clin Exp Allergy; 2006 May; 36(5):658-65. PubMed ID: 16650052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing allergenicity by altering allergen fold: a mosaic protein of Phl p 1 for allergy vaccination.
    Ball T; Linhart B; Sonneck K; Blatt K; Herrmann H; Valent P; Stoecklinger A; Lupinek C; Thalhamer J; Fedorov AA; Almo SC; Valenta R
    Allergy; 2009 Apr; 64(4):569-80. PubMed ID: 19243361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a hypoallergenic recombinant Bet v 1 variant as a candidate for allergen-specific immunotherapy.
    Kahlert H; Suck R; Weber B; Nandy A; Wald M; Keller W; Cromwell O; Fiebig H
    Int Arch Allergy Immunol; 2008; 145(3):193-206. PubMed ID: 17912007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoallergenic mutants of Ole e 1, the major olive pollen allergen, as candidates for allergy vaccines.
    Marazuela EG; Rodríguez R; Barber D; Villalba M; Batanero E
    Clin Exp Allergy; 2007 Feb; 37(2):251-60. PubMed ID: 17250698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune recognition of novel isoforms and domains of the mugwort pollen major allergen Art v 1.
    Dedic A; Gadermaier G; Vogel L; Ebner C; Vieths S; Ferreira F; Egger M
    Mol Immunol; 2009 Jan; 46(3):416-21. PubMed ID: 19054564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Allergen engineering": variants of the timothy grass pollen allergen Phl p 5b with reduced IgE-binding capacity but conserved T cell reactivity.
    Schramm G; Kahlert H; Suck R; Weber B; Stüwe HT; Müller WD; Bufe A; Becker WM; Schlaak MW; Jäger L; Cromwell O; Fiebig H
    J Immunol; 1999 Feb; 162(4):2406-14. PubMed ID: 9973522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the polypeptide backbone and post-translational modifications in cross-reactivity of Art v 1, the major mugwort pollen allergen.
    Gruber P; Gadermaier G; Bauer R; Weiss R; Wagner S; Leonard R; Breiteneder H; Ebner C; Ferreira F; Egger M
    Biol Chem; 2009; 390(5-6):445-51. PubMed ID: 19361284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of sensitization to Artemisia allergens Art v 1, Art v 3 and Art v 60 kDa. Cross-reactivity among Art v 3 and other relevant lipid-transfer protein allergens.
    Lombardero M; García-Sellés FJ; Polo F; Jimeno L; Chamorro MJ; García-Casado G; Sánchez-Monge R; Díaz-Perales A; Salcedo G; Barber D
    Clin Exp Allergy; 2004 Sep; 34(9):1415-21. PubMed ID: 15347375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen presentation of the immunodominant T-cell epitope of the major mugwort pollen allergen, Art v 1, is associated with the expression of HLA-DRB1 *01.
    Jahn-Schmid B; Fischer GF; Bohle B; Faé I; Gadermaier G; Dedic A; Ferreira F; Ebner C
    J Allergy Clin Immunol; 2005 Feb; 115(2):399-404. PubMed ID: 15696102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Date palm pollen allergoid: characterization of its chemical-physical and immunological properties.
    Mistrello G; Harfi H; Roncarolo D; Kwaasi A; Zanoni D; Falagiani P; Panzani R
    Int Arch Allergy Immunol; 2008; 145(3):224-30. PubMed ID: 17914274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody-based ELISA to quantify the major allergen of Artemisia vulgaris pollen, Art v 1.
    Jimeno L; Duffort O; Serrano C; Barber D; Polo F
    Allergy; 2004 Sep; 59(9):995-1001. PubMed ID: 15291909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of a low immunoglobulin E-binding mutant of the timothy grass pollen major allergen Phl p 5a.
    Wald M; Kahlert H; Weber B; Jankovic M; Keller W; Cromwell O; Nandy A; Fiebig H
    Clin Exp Allergy; 2007 Mar; 37(3):441-50. PubMed ID: 17359394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of allergen composition and in vivo immunogenicity of depigmented allergoids of Betula alba.
    Carnés J; Himly M; Gallego M; Iraola V; Robinson DS; Fernández-Caldas E; Briza P
    Clin Exp Allergy; 2009 Mar; 39(3):426-34. PubMed ID: 19134021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning, expression and characterization of mugwort pollen allergen Art v 2, a pathogenesis-related protein from family group 1.
    Arilla MC; Ibarrola I; Puente Y; Daza JC; Martínez A; Asturias JA
    Mol Immunol; 2007 Jul; 44(15):3653-60. PubMed ID: 17521730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of common allergenic structures in mugwort and ragweed pollen.
    Hirschwehr R; Heppner C; Spitzauer S; Sperr WR; Valent P; Berger U; Horak F; Jäger S; Kraft D; Valenta R
    J Allergy Clin Immunol; 1998 Feb; 101(2 Pt 1):196-206. PubMed ID: 9500752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Native Art v 1 and recombinant Art v 1 are able to induce humoral and T cell-mediated in vitro and in vivo responses in mugwort allergy.
    Schmid-Grendelmeier P; Holzmann D; Himly M; Weichel M; Tresch S; Rückert B; Menz G; Ferreira F; Blaser K; Wüthrich B; Crameri R
    J Allergy Clin Immunol; 2003 Jun; 111(6):1328-36. PubMed ID: 12789236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgE reactivity patterns in patients with allergic rhinoconjunctivitis to ragweed and mugwort pollens.
    Canis M; Becker S; Gröger M; Kramer MF
    Am J Rhinol Allergy; 2012; 26(1):31-5. PubMed ID: 22391077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine and antibody responses in birch-pollen-allergic patients treated with genetically modified derivatives of the major birch pollen allergen Bet v 1.
    Gafvelin G; Thunberg S; Kronqvist M; Grönlund H; Grönneberg R; Troye-Blomberg M; Akdis M; Fiebig H; Purohit A; Horak F; Reisinger J; Niederberger V; Akdis CA; Cromwell O; Pauli G; Valenta R; van Hage M
    Int Arch Allergy Immunol; 2005 Sep; 138(1):59-66. PubMed ID: 16103688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.